The process development challenge for a new vaccine

被引：67

作者：

Buckland, BC ^{[1
]}

机构：

[1] Merck Res Labs, West Point, PA 19486 USA

来源：

NATURE MEDICINE | 2005年 / 11卷 / 04期

关键词：

D O I：

10.1038/nm1218

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The challenges of vaccine development are not limited to identification of suitable antigens, adjuvants and delivery methods, but include regulatory, technical and manufacturing hurdles in translating a vaccine candidate to the clinic. Process development is the technological foundation that underlies the manufacture of new vaccines and is central to successful commercialization.

引用

页码：S16 / S19

页数：4

共 8 条

[1] Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine
Brown, DR
Fife, KH
Wheeler, CM
Koutsky, LA
Lupinacci, LM
Railkar, R
Suhr, G
Barr, E
Dicello, A
Li, WL
Smith, JF
Tadesse, A
Jansen, KU
[J]. VACCINE, 2004, 22 (21-22) : 2936 - 2942
[2] Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants
Clark, HF
Bernstein, DI
Dennehy, PH
Offit, P
Pichichero, M
Treanor, J
Ward, RL
Krah, DL
Shaw, A
Dallas, MJ
Digilio, L
Eiden, JJ
Ivanoff, N
Kaplan, KM
Heaton, P
[J]. JOURNAL OF PEDIATRICS, 2004, 144 (02) : 184 - 190
[3] Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation
Clark, HF
Burke, CJ
Volkin, DB
Offit, P
Ward, RL
Bresee, JS
Dennehy, P
Gooch, WM
Malacaman, E
Matson, D
Walter, E
Watson, B
Krah, DL
Dallas, MJ
Schödel, F
Kaplan, KM
Heaton, P
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (10) : 914 - 920
[4] Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women
Fife, KH
Wheeler, CM
Koutsky, LA
Barr, E
Brown, DR
Schiff, MA
Kiviat, NB
Jansen, KU
Barber, H
Smith, JF
Tadesse, A
Giacoletti, K
Smith, PR
Suhr, G
Johnson, DA
[J]. VACCINE, 2004, 22 (21-22) : 2943 - 2952
[5] VACCINATION WITH YEAST-EXPRESSED COTTONTAIL RABBIT PAPILLOMAVIRUS (CRPV) VIRUS-LIKE PARTICLES PROTECTS RABBITS FROM CRPV-INDUCED PAPILLOMA FORMATION
JANSEN, KU
ROSOLOWSKY, M
SCHULTZ, LD
MARKUS, HZ
COOK, JC
DONNELLY, JJ
MARTINEZ, D
ELLIS, RW
SHAW, AR
[J]. VACCINE, 1995, 13 (16) : 1509 - 1514
[6] KNICKSEN PJ, 1992, VACCINES NEW APPROAC, P177
[7] A controlled trial of a human papillomavirus type 16 vaccine
Koutsky, LA
Ault, KA
Wheeler, CM
Brown, DR
Barr, E
Alvarez, FB
Chiacchierini, LM
Jansen, KU
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) : 1645 - 1651
[8] Pisano G., 1997, The Development Factory

← 1 →